Skip to main content
Premium Trial:

Request an Annual Quote

Oncocyte: Joshua Riggs

Oncocyte has appointed Joshua Riggs as CEO effective Feb. 24, 2023. Riggs was named interim CEO in December, after serving as director of business development and general manager of transplant beginning in 2020. He also serves as president and joins the company's board of directors. Prior to joining Oncocyte, Riggs was a business development strategist with experience working with growth-stage molecular diagnostics companies. He has also served as a principal at Bethesda Group.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.